Delivery Order SPE2DB24D3013-SPE2DB24FFGWK

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a ceiling value of $1,022.38 and a performance period through April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
This is a $1,778.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range...
This is a $3,205.79 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of April 15, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a $1,493.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug XULANE 150-35 MCG/DAY PATCH 3S and has an ultimate completion date of April 15, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary...
This is a $9,621.20 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a potential value of $1,252.68 and a completion date of February 27, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,951.68, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The delivery order has an ultimate completion date of October 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $2,253.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a period of performance through July 9, 2024. This order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The contract has a ceiling value of $1,188.15 and a completion date of April 11, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,605.17, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical supply. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGWK
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $10,418.24 firm-fixed price delivery order to Amerisourcebergen Drug Corporation's Corporate Office division for the supply of XULANE 150-35 MCG/DAY PATCH 3S. This delivery order was placed against an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of August 13, 2024, and no set-aside designation was used.

Generated 11/11/24, 9:28 AM